Nutritionally induced insulin resistance and receptor defect leading to β-cell failure in animal models

Annals of the New York Academy of Sciences

Volumn 892, Issue , 1999, Pages 223-246

  Shafrir, Eleazar ^a   Ziv, Ehud ^a   Mosthaf, Luitgard ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN RECEPTOR; LIVER ENZYME; MESSENGER RNA; MUSCLE ENZYME; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; SERINE; THREONINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CALORIC INTAKE; CONFERENCE PAPER; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; GERBIL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIVER METABOLISM; MOUSE; MUSCLE TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITION; NUTRITIONAL STATUS; PANCREAS ISLET BETA CELL; PHOSPHORYLATION; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

EID: 0032763007     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07798.x     Document Type: Conference Paper

References (88)

1. 1. Shafrir, E. 1992. Animal models of non-insulin-dependent diabetes. Diabetes Metab. Rev. 8: 179-208.
2. 2. Shafrir, E. 1997. Diabetes in animals, contribution to the understanding of diabetes by study of its etiopathology in animal models. In Diabetes Mellitus. D. Porte, Jr. & R. Sherwin, Eds.: 301-348. Appleton & Lange. Norwalk, CT.
3. 3. Shafrir, E. 1996. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes Metab. 22: 122-131.
4. 4. Shafrir, E. 1993. The plurimetabolic syndrome in animals: models for experimentation, their implication and relation to NIDDM. In Diabetes, Obesity and Hyperlipidemia. G. Crepaldi, A. Tiengo & E. Manzato, Eds.: 45-55. Elsevier Science. Amsterdam.
5. 5. Like, A. A. & W. L. Chick. 1970. Studies in the diabetic mutant mouse. I. Light microscopy and radioautography of pancreatic islets. Diabetologia 6: 207-215.
6. 6. Like, A. A. & W. L. Chick. 1970. Studies on the diabetic mutant mouse. II. Electron microscopy of pancreatic islets. Diabetologia 6: 216-242.
7. 7. Ziv, E. & E. Shafrir. 1995. Psammomys obesus: nutritionally induced NIDDM-like syndrome on a "thrifty gene" background. In Lessons from Animal Diabetes, Vol. 5. E. Shafrir, Ed.: 285-300. Smith-Gordon. London.
8. 8. Bar-On, H., R. Ben-Sasson, E. Ziv, N. Arar & E. Shafrir. 1999. Irreversibility of nutritionally induced NIDDM in Psammomys obesus is related to β-cell apoptosis. Pancreas In press.
9. 9. Pick, A., J. Clark, C. Kubstrup, M. Levisetti, et al. 1998. Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat. Diabetes 47: 358-364.
10. 10. Kalderon, B., A. Gutman, E. Shafrir & J. H. Adler. 1986. Characterization of stages in the development of obesity-diabetes syndrome in sand rat (Psammomys obesus). Diabetes 35: 717-724.
11. 11. Granner, D. K. & T. L. Andreone. 1985. Insulin modulation of gene expression. In Diabetes Metab. Rev. 1: 139-170.
12. 12. Gadot, M., G. Leibowitz, E. Shafrir, E. Cerasi, D. J. Gross & N. Kaiser. 1994. Hyperproinsulinemia and insulin deficiency in the diabetic Psammomys obesus. Endocrinology 135: 610-616.
13. 13. Ward, W. K., E. C. Lacava, T. L. Paquette, J. C. Beard, B. J. Wallum & D. Porte. 1987. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin) diabetes mellitus and in experimental insulin resistance. Diabetologia 30: 698-702.
14. 14. Glauber, H. S., R. R. Revers, R. Henry, L. Schmeiser, P. Wallace, O. G. Kolterman, R. M. Cohen, A. H. Rubenstein, J. A. Galloway, B. H. Frank & J. M. Olefsky. 1986. In vivo deactivation of proinsulin action on glucose disposal and hepatic glucose production in normal man. Diabetes 35: 311-317.
15. 15. Coleman, D. L. 1983. Lessons from studies with genetic forms of diabetes in the mouse. Metabolism 32: 162-164.
16. 16. Hansen, B. C., N. L. Bodkin, J. Schwartz & K. L. C. Jen. 1988. B-cell responses, insulin resistance and the natural history of noninsulin-dependent diabetes in obese rhesus monkeys. In Lessons from Animal Diabetes, Vol. 2. E. Shafrir & A. E. Renold, Eds.: 644-649. J. Libbey. London.
17. 17. Polonsky, K., J. Sturis & G. J. Bell. 1996. Non-insulin-dependent diabetes mellitus - A genetically programmed failure of the beta cell to compensate for insulin resistance. N. Engl. J. Med. 334: 777-783.
18. 18. Shafrir, E. 1988. Nonrecognition of insulin as gluconeogenesis suppressant - manifestation of selective hepatic insulin resistance in several animal species with type II diabetes: sand rats, spiny mice and db/db mice. In Lessons from Animal Diabetes, Vol. 2. E. Shafrir & A. E. Renold, Eds.: 304-315. J. Libbey. London.
19. 19. Shargill, N. S., A. Tatoyan, M. F. El-Refai, M. Pleta & T. M. Chan. 1986. Impaired insulin receptor phosphorylation in skeletal muscle membranes of db/db mice: the use of a novel skeletal muscle plasma membrane preparation to compare insulin binding and simulation of receptor phosphorylation. Biochem. Biophys. Res. Commun. 137: 286-294.
20. 20. Gibbs, E. M., J. L. Stock, S. C. McCold, H. A. Stukenbrok, J. E. Pessin, R. A. Stevenson, A. J. Milici & J. D. McNeish. 1995. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable transporter (GLUT4). J. Clin. Invest. 95: 1512-1518.
21. 21. Like, A. A. & E. Miki. 1967. Diabetic syndrome in sand rats. IV Morphologic changes islet tissue. Diabetologia 3: 143-166.
22. 22. Leiter, E. H., D. L. Coleman, A. B. Eisenstein & I. Strack. 1981. Dietary control of pathogenesis in C57BL/KsJ db/db diabetes mice. Metabolism 30: 554-562.
23. 23. Leiter, E. H., D. L. Coleman, D. K. Ingram & M. A. Reynold. 1983. Influence of dietary carbohydrate on the induction of diabetes in C57BL/KsJ-db/db diabetes mice. J. Nutr. 113: 184-195.
24. 24. Coleman, D. L. & K. P. Hummel. 1975. Influence of genetic background on the expression of mutations at the diabetic locus in the mouse. II. Studies on background modifiers. Isr. J. Med. Sci. 11: 708-713.
25. 25. Leiter, E. H. 1989. The genetics of diabetes susceptibility in mice. FASEB J. 3: 2231-2241.
26. 26. Leiter, E. H. 1987. Analysis of differential survival of syngeneic islets transplanted into hyperglycemic C57BL/6J versus C57BL/KsJ mice. Transplantation 44: 401-406.
27. 27. Surwit, R. S., C. M. Kuhn, C. Cochrane, J. A. McCubbin & M. N. Feingloss. 1988. Diet-induced type 2 diabetes in C57BL/6J mice. Diabetes 37: 1163-1167.
28. 28. Hansen, B. C., H. K. Ortmeyer & N. L. Bodkin. 1995. Obesity, insulin resistance, and non-insulin-dependent diabetes mellitus in aging monkeys: implications for NIDDM in humans. In Lessons from Animal Diabetes, Vol. 5. E. Shafrir, Ed.: 93-105. Smith-Gordon. London.
29. 29. De Koning, E. J. P., N. L. Bodkin, B. C. Hansen & A. Clark. 1993. Diabetes mellitus in Macaca mulatta monkeys is characterized by islet amyloidosis and reduction in beta-cell population. Diabetologia 36: 378-384.
30. 30. Tokuyama, Y., J. Sturis, A. M. Depaoli, J. Takeda, M. Stoffel, J. Tang, X. Sun, K. S. Polonsky & G. I. Bell. 1995. Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44: 1447-1457.
31. 31. Orci, L., M. Ravazzola, D. Baetens, L. Inman, M. Amherdt, R. G. Peterson, C. B. Newgard, J. H. Johnson & R. H. Unger. 1990. Evidence that downregulation of B-cell glucose transporters in non-insulin dependent diabetes may be the cause of diabetic hyperglycemia. Proc. Natl. Acad. Sci. U.S.A. 87: 9953-9957.
32. 32. Unger, R. H. 1995. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: Genetic and clinical implications. Diabetes 44: 863-870.
33. 33. Miles, P. D. G., S. Li, M. Hart, O. Romeo, J. Cheng, A. Cohen, K. Raafat, A. R. Moossa & J. M. Olefsky. 1998. Mechanisms of insulin resistance in experimental hyperinsulinemic dogs. J. Clin. Invest. 101: 202-211.
34. 34. Striffler, J. S. & D. L. Curry. 1979. Effect of fasting on insulin removal by liver of perfused liver-pancreas. Am. J. Physiol. 237: E349-E355.
35. 35. Chap, Z., T. Ishida, J. Chou, C. J. Hartley, M. L. Entman, D. Brandenburg, R. H. Jones & J. B. Field. 1987. First-pass hepatic extraction and metabolic effects of insulin and insulin analogues. Am. J. Physiol. 252: E209-E217.
36. 36. Del Prato, S., F. Leonetti, D. C. Simonson, P. Sheehan, M. Matsuola & R. A. De Fronzo. 1994. Diabetologia 37: 1025-1034.
37. 37. Kraegen, E. W., J. A. Sowden, M. B. Halstead, P. W. Clark, K. J. Rodnick, D. J. Chisholm & D. E. James. 1993. Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4. Biochem. J. 295: 287-293.
38. 38. Storlien, L. H., D. E. James, K. M. Burleigh, D. J. Chisholm & E. W. Kraegen. 1987. Fat feeding causes widespread insulin resistance, decreased energy expenditure and obesity in rats. Am. J. Physiol. 251: E576-E583.
39. 39. Kraegen, E. W., P. W. Clark, A. B. Jenkins, E. Daley, D. J. Chisholm & L. H. Storlien. 1991. Muscle insulin resistance develops after liver insulin resistance in the high fat fed rat. Diabetes 40: 1397-1403.
40. 40. Wang, J., J. T. Alexander, P. Zheng, H. J. Yu, J. Dourmashkin & S. F. Leibowitz. 1998. Behavioral and endocrine traits of obesity-prone and obesity-resistant rats on macronutrient diets. Endocrinol. Metab. 274: E1057-E1066.
41. 41. Shafrir, E. 1982. Intermediary metabolism during the development of obesity and diabetes in the desert rodent Acomys cahirinus. Int. J. Obesity 6: 9-20.
42. 42. Pan, D. A., S. Lillioja, M. R. Milner, A. D. Kriketos, L. A. Baur, C. Bogardus & L. H. Storlien. 1995. Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J. Clin. Invest. 96: 2802-2808.
43. 43. Schmitz-Peiffer, C., C. L. Browne, N. D. Oakes, A. Watkinson, D. J. Chisholm, E. W. Kraegen & T. J. Biden. 1997. Alterations in the expression and cellular localization of protein kinase C isozymes ε and θ are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46: 169-178.
44. 44. Hackel, D. B., L. A. Frohman, E. Mikat, H. E. Lebovitz, K. Schmidt-Nielsen & T. D. Kinney. 1965. Review of the current studies on effect of diet on the glucose tolerance of the sand rat (Psammomys obesus). Ann. N.Y. Acad. Sci. 131: 459-463.
45. 45. Kalman, R., J. H. Adler, G. Lazarovici, H. Bar-On & E. Ziv. 1993. The efficiency of sand rat metabolism is responsible for development of obesity and diabetes. J. Basic Clin. Physiol. Pharmacol. 4: 83-99.
46. 46. Marquie, G., J. Duhault & B. Jacotot. 1984. Diabetes mellitus in sand rat (Psammomys obesus). Metabolic pattern during development of the diabetic syndrome. Diabetes 135: 438-443.
47. 47. Barnett, M., G. R. Collier, F. M. Collier, P. Zimmet & K. O'Dea. 1994. A cross-sectional and short-term longitudinal characterization of NIDDM in Psammomys obesus. Diabetologia 37: 671-676.
48. 48. Ziv, E., R. Kalman, K. Hershkop, V Barash, E. Shafrir & H. Bar-On. 1996. Insulin resistance in the NIDDM model Psammomys obesus in the normoglycemic, normoinsulinemic state. Diabetologia 39: 1269-1275.
49. 49. Neel, J. V. 1963. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am. J. Hum. Genet. 14: 353-362.
50. 50. Kanety, H., S. Moshe, E. Shafrir, B. Lunenfeld & A. Karasik. 1994. Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. U.S.A. 91: 1853-1857.
51. 51. Ziv, E., I. Nachliel, H. Bar-On & E. Shafrir. 1997. Nutritionally induced insulin resistance in Psammomys obesus, its consequences and its possible prevention. Exp. Clin. Endocrinol. Diabetes 105: 12-13.
52. 52. Barnett, M., G. R. Collier, P. Zimmet & K. O'Dea. 1994. The effect of restricting energy intake on diabetes in Psammomys obesus. Int. J. Obesity 18: 789-794.
53. 53. Ohneda, M., L. R. Inman & R. H. Unger. 1995. Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia 38: 173-179.
54. 54. Meyerovitch, J., J. M. Backer & C. R. Kahn. 1989. Hepatic phosphotyrosine phosphatase activity and its alteration in diabetic rats. J. Clin. Invest. 44: 976-983.
55. 55. Mooney, R. A., D. T. Kulas, L. A. Bleyle & J. S. Novak. 1997. The protein tyrosine phosphatase LAR has a major impact on insulin receptor dephosphorylation. Biochem. Biophys. Res. Commun. 235: 709-712.
56. 56. Ahmad, F. & B. J. Goldstein. 1995. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus. Metabolism 44: 1175-1184.
57. 57. Ahmad, F., R. V. Considine & B. J. Goldstein. 1995. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR account for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J. Clin. Invest. 95: 2806-2812.
58. 58. Shafrir, E., L. Mosthaf, A. Saha, N. B. Ruderman, R. Kalman, Y. Meyerovitch, Y. Balta, H. Bar-On & E. Ziv. 1998. Mechanism of nutritionally induced insulin resistance in an NIDDM model: Psammomys obesus. 7th International Symposium on Insulin Receptors & Insulin Action (Abstracts). Jerusalem, Israel. Communication O-52.: 87-89.
59. 59. Prochazka, M., H. Mochizuki, L. J. Baier, P. T. W. Cohen & C. Bogardus. 1995. Molecular and linkage analysis of type-1 protein phosphatase catalytic beta subunit gene: lack of evidence for its major role in insulin resistance in Pima Indians. Diabetologia 38: 461-466.
60. 60. Karasik, A., P. L. Rothenberg, K. Yamada, M. F. White & C. R. Kahn. 1990. Protein kinase C is involved in physiologic modulation of the insulin receptor kinase. J. Biol. Chem. 265: 10226-10231.
61. 61. Chin, J. E., F. Liu & R. A. Roth. 1994. Activation of protein kinase Cα inhibits insulinstimulated tyrosine phosphorylation of insulin receptor substrate-1. Mol. Endocrinol. 8: 51-58.
62. 62. Haring, H. U., M. Kellerer & L. Mosthaf. 1994. Modulation of insulin signaling in non-insulin-dependent diabetes mellitus: significance of altered receptor isoform patterns and mechanisms of glucose-induced receptor modulation. Horm. Res. 41(Suppl. 2): 87-92.
63. 63. Bossenmaier, B., L. Mosthaf, H. Mischak, A. Ullrich & H. U. Haring. 1997. Protein kinase C isoforms β1 and β2 inhibit the tyrosine kinase activity of the insulin receptor. Diabetologia 40: 863-866.
64. 64. Tanti, J-F., T. Gremeaux, E. Van Obberghen & Y. Le Marchand-Brustel. 1994. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates receptor signaling. J. Biol. Chem. 269: 6051-6057.
65. 65. Muller, H. K., M. Kellerer, B. Ermel, A. Muhlhofer, B. Obermaier-Kusser, B. Vogt & H. U. Haring. 1991. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells. Diabetes 40: 1440-1448.
66. 66. Ikeda, Y., E. Ziv, L. L. Hansen, A. K. Busch, B. F. Hansen, E. Shafrir & L. Mosthaf. 1999. Cellular mechanism of nutritionally induced insulin resistance in Psammomys obesus: overexpression of protein kinase C epsilon in skeletal muscle precedes the onset of hyperinsulinemia and hyperglycemia. Diabetes 48: A76.
67. 67. Xia, I., T. Inoguchi, T. S. Kern, R. L. Engerman, P. J. Oates & G. L. King. 1994. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43: 1122-1129.
68. 68. Inoguchi, T., R. Battan, E. Handler, J. R. Sportsman, W. Heath & G. L. King. 1992. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats; differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. U.S.A. 89: 11059-11063.
69. 69. Danielsen, A. G., F. Liu, Y. Hosomi, K. Shii & R. A. Roth. 1995. Activation of protein kinase C inhibits signaling by members of the insulin receptor family. J. Biol. Chem. 270: 21600-21605.
70. 70. Busch, A. K., I. Castan, E. Degerman, H. Tornqvist & L. Mosthaf. 1998. Protein kinase C mediates hyperglycemia induced insulin resistance through serine phosphorylation of IRS-1. Diabetologia 41(Suppl. 1): A10.
71. 71. Kellerer, M., J. Mushack, H. Mischak & H. U. Haring. 1997. Protein kinase C (PKC)ε enhances the inhibitory effect of TNFα on insulin signaling in HEK 293 cells. FEBS Lett. 418: 119-122.
72. 72. Avignon, A., K. Yamada, X. Zhou, B. Spencer, O. Cardona, S. Saba-Siddique, L. Galloway, M. L. Standaert & R. V. Farese. 1996. Chronic activation of protein kinase C in soleus muscles and other tissues of insulin resistant type II diabetic Goto-Kakizaki (GK), obese/aged and obese Zucker rats. Diabetes 45: 1396-1404.
73. 73. Shafrir, E., R. Ben-Sasson, E. Ziv & H. Bar-On. 1999. Insulin resistance, beta cell survival and apoptosis in type 2 diabetes: animal models and human implications. Diabetes Rev. 7: 114-123.
74. 74. Purrello, F., M. Vetri, C. Gatta, D. Gullo & R. Vigneri. 1989. Effects of high glucose on insulin secretion by isolated rat islets and purified β-cells and possible role of glycosylation. Diabetes 38: 1417-1422.
75. 75. Eizirik, D. L., G. S. Korbutt & C. Hellerstrom. 1992. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the β-cell function. J. Clin. Invest. 90: 1263-1268.
76. 76. Donath, M. Y., D. J. Gross, E. Cerasi & N. Kaiser. 1999. Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48: 738-744.
77. 77. Kaneto, H., J. Fujii, T. Myint, N. Miyazawa, K. Islam, Y. Kawasaki, K. Suzuki, M. Nakamura, H. Tatsumi, Y. Yamasaki & N. Taniguchi. 1996. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem. J. 320: 855-863.
78. 78. Saini, K. S., C. Thompson, C. M. Winterford, N. I. Walker & D. P. Cameron. 1966. Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1. Biochem. Mol. Biol. Int. 39: 1229-1236.
79. 79. O'Brien, B. A., B. V. Harmon, D. P. Cameron & D. J. Allan. 1997. Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 46: 750-757.
80. 80. DeFronzo, R. A. & E. Ferrannini. 1991. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194.
81. 81. Sacks, D. B. & J. M. MacDonald. 1996. The pathogenesis of type II diabetes mellitus. A polygenic disease. Am. J. Clin. Pathol. 105: 149-156.
82. 82. McCarthy, M. F. 1995. Upregulation of intracellular signaling pathways may play a central pathogenic role in hypertension, atherogenesis, insulin resistance and cancer promotion - the "PKC syndrome." Mol. Hypotheses 46: 190-221.
83. 83. Reaven, G. M. 1997. Syndrome X - past, present and future. In Diabetes and Obesity, Vol. II. B. Draznin & R. Rizza, Eds.: 357-382. Human Press Inc. Totowa, NJ.
84. 84. Modan, M., H. Halkin, S. Almog, A. Lusky, A. Eshkol, M. Shefi, A. Shitrit & Z. Fuchs. 1985. Hyperinsulinemia, a link between hypertension, obesity and glucose intolerance. J. Clin. Invest. 75: 809-817.
85. 85. Crepaldi, G. & B. Nosadini. 1988. Diabetic cardiopathy: is it a real entity? Diabetes Metab. Rev. 4: 273-288.
86. 86. Kaplan, N. M. 1989. The deadly quartet: upper body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 149: 1514-1520.
87. 87. Reaven, G. M. 1991. Insulin resistance, hyperinsulinemia, hypertriglyceridemia and hypertension: parallels between human disease and rodent models. Diabetes Care 14: 195-202.
88. 88. Zimmet, P. & K. O'Dea. 1993. Thrifty genotypes. In Causes of Diabetes. R. D. G. Leslie, Ed.: 269-290. J. Wiley & Sons. London.